Properties of PEI-based polyplex nanoparticles that correlate with their transfection efficacy

Molecular Therapy

Volumn 19, Issue 1, 2011, Pages 103-112

  Ulasov, Alexey V ^a   Khramtsov, Yuri V ^a   Trusov, Georgiy A ^a,b   Rosenkranz, Andrey A ^a,b   Sverdlov, Eugene D ^c,d   Sobolev, Alexander S ^a,b  

^a INSTITUTE OF GENE BIOLOGY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

^d SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

MACROGOL; NANOPARTICLE; NITROGEN; PHOSPHATE; PLASMID DNA; POLYETHYLENEIMINE; QUANTUM DOT;

ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER CELL CULTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGHT SCATTERING; NONHUMAN; PARTICLE SIZE; SYNTHESIS; TRANSPORT KINETICS;

EID: 78650878303     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.233     Document Type: Article

References (37)

1. Edelstein, ML, Abedi, MR and Wixon, J (2007). Gene therapy clinical trials worldwide to 2007-an update. J Gene Med 9: 833-842.
2. Cho, CW, Cho, YS, Kang, BT, Hwang, JS, Park, SN and Yoon, DY (2001). Improvement of gene transfer to cervical cancer cell lines using non-viral agents. Cancer Lett 162: 75-85.
3. Nakamura, T, Moriguchi, R, Kogure, K, Minoura, A, Masuda, T, Akita, H et al. (2006). Delivery of condensed DNA by liposomal non-viral gene delivery system into nucleus of dendritic cells. Biol Pharm Bull 29: 1290-1293.
4. He, CX, Tabata, Y and Gao, JQ (2010). Non-viral gene delivery carrier and its three-dimensional transfection system. Int J Pharm 386: 232-242.
5. Grigsby, CL and Leong, KW (2010). Balancing protection and release of DNA: tools to address a bottleneck of non-viral gene delivery. J R Soc Interface 7 Suppl 1: S67-S82.
6. Schaffer, DV and Lauffenburger, DA (1998). Optimization of cell surface binding enhances effciency and specifcity of molecular conjugate gene delivery. J Biol Chem 273: 28004-28009.
7. Plank, C, Oberhauser, B, Mechtler, K, Koch, C and Wagner, E (1994). The infuence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J Biol Chem 269: 12918-12924.
8. Capecchi, MR (1980). High effciency transformation by direct microinjection of DNA into cultured mammalian cells. Cell 22(2 Pt 2): 479-488.
9. Schaffer, DV, Fidelman, NA, Dan, N and Lauffenburger, DA (2000). Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol Bioeng 67: 598-606.
10. Chen, HH, Ho, Y P, Jiang, X, Mao, HQ, Wang, TH and Leong, KW (2008). Quantitative comparison of intracellular unpacking kinetics of polyplexes by a model constructed from quantum dot-FRET. Mol Ther 16: 324-332.
11. Hillaireau, H and Couvreur, P (2009). Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 66: 2873-2896.
12. Merdan, T, Kunath, K, Petersen, H, Bakowsky, U, Voigt, KH, Kopecek, J et al. (2005). PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice. Bioconjug Chem 16: 785-792.
13. Ogris, M, Walker, G, Blessing, T, Kircheis, R, Wolschek, M and Wagner, E (2003). Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes. J Control Release 91: 173-181.
14. Neu, M, Fischer, D and Kissel, T (2005). Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med 7:992-1009.
15. Mintzer, MA and Simanek, EE (2009). Nonviral vectors for gene delivery. Chem Rev 109: 259-302.
16. Merdan, T, Callahan, J, Petersen, H, Kunath, K, Bakowsky, U, Kopecková, P et al. (2003). Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. Bioconjug Chem 14:989-996.
17. Rudolph, C, Plank, C, Lausier, J, Schillinger, U, Müller, RH and Rosenecker, J (2003). Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem 278: 11411-11418.
18. Hashida, H, Miyamoto, M, Cho, Y, Hida, Y, Kato, K, Kurokawa, T et al. (2004). Fusion of HIV-1 Tat protein transduction domain to poly-lysine as a new DNA delivery tool. Br J Cancer 90: 1252-1258.
19. Hyndman, L, Lemoine, JL, Huang, L, Porteous, DJ, Boyd, AC, Nan, X (2004). HIV-1 TAT protein transduction domain peptide facilitates gene transfer in combination with cationic liposomes. J Control Release 99: 435-444.
20. Kleemann, E, Neu, M, Jekel, N, Fink, L, Schmehl, T, Gessler, T et al. (2005). Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. J Control Release 109: 299-316.
21. Wiethoff, CM and Middaugh, CR (2001). Light-scattering techniques for characterization of synthetic gene therapy vectors. In: Findeis, MA (ed). Nonviral Vectors for Gene Therapy and Protocol (Methods in Molecular Medicine series, vol. 65). Humana Press: Totowa, NJ. pp. 349-376.
22. Ho, Y P, Chen, HH, Leong, KW and Wang, TH (2006). Evaluating the intracellular stability and unpacking of DNA nanocomplexes by quantum dots-FRET. J Control Release 116: 83-89.
23. Periasamy, A, Day, RN (eds) (2005). Molecular Imaging. FRET microscopy and spectroscopy. Oxford University Press, Inc., New York, 312pp.
24. Kremer, TM, Rinne, ML, Xu, Y, Chen, XM and Kelley, MR (2004). Protection of pulmonary epithelial cells from oxidative stress by hMYH adenine glycosylase. Respir Res 5: 16.
25. TM, . http://www.lgcstandards-atcc.org/LGCAdvancedCatalogueSearch/ProductDescription/ tabid/1068/Default. aspx?ATCCNum=CCL-185&Template=cellBiology.
26. TM, . http://www.lgcstandards-atcc. org/LGCAdvancedCatalogueSearch/ProductDescription/ tabid/1068/Default. aspx?ATCCNum=HTB-54&Template=cellBiology
27. Abdel-Malek, ZA, Swope, VB, Amornsiripanitch, N and Nordlund, JJ (1987). In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandins. Cancer Res 47: 3141-3146.
28. Smrekar, B, Wightman, L, Wolschek, MF, Lichtenberger, C, Ruzicka, R, Ogris, M et al. (2003). Tissue-dependent factors affect gene delivery to tumors in vivo. Gene Ther 10: 1079-1088.
29. Iida, T, Mori, T, Katayama, Y and Niidome, T (2007). Overall interaction of cytosolic proteins with the PEI/DNA complex. J Control Release 118: 364-369.
30. Perrine, TD and Landis, WR (1967). Analysis of polyethylenimine by spectrophotometry of its copper chelate. J Polym Sci A1 5: 1993-2003.
31. Kunath, K, von Harpe, A, Petersen, H, Fischer, D, Voigt, K, Kissel, T et al. (2002). The structure of PEG-modifed poly(ethylene imines) infuences biodistribution and pharmacokinetics of their complexes with NF-kappaB decoy in mice. Pharm Res 19: 810-817.
32. Gong, XW, Wei, DZ, He, ML and Xiong, YC (2007). Discarded free PEG-based assay for obtaining the modifcation extent of pegylated proteins. Talanta 71: 381-384.
33. Vaidyanathan, G and Zalutsky, MR (2006). Preparation of N-succinimidyl 3-[*I] iodobenzoate: an agent for the indirect radioiodination of proteins. Nat Protoc 1: 707-713.
34. Dunn, WA, Hubbard, AL and Aronson, NN Jr (1980). Low temperature selectively inhibits fusion between pinocytic vesicles and lysosomes during heterophagy of 125I-asialofetuin by the perfused rat liver. J Biol Chem 255: 5971-5978.
35. Labelling of proteins with CyDye N-hydroxysuccinimide esters for fuorescent applications on the LEADseeker homogeneous imaging system. Amersham Biosciences Protocol. (January 2001) L8: p. 4.
36. Wheat germ agglutinin conjugates. Protocol of Molecular Probes Inc., 16 March,(2009) MP 00831, p. 4.
37. Akita, H, Ito, R, Khalil, IA, Futaki, S and Harashima, H (2004). Quantitative three-dimensional analysis of the intracellular traffcking of plasmid DNA transfected by a nonviral gene delivery system using confocal laser scanning microscopy. Mol Ther 9: 443-451.